Investment Thesis for Galectin Therapeutics, Inc. (NASDAQ: GALT)

Abstract

This working paper is an in-depth analysis of Galectin Therapeutics, Inc. Our analysis examines the economic factors that impact GALT’s underlying business and how GALT has adapted to these everchanging factors. This economic analysis is then combined with our proprietary Net present value (NPV) model to determine GALT’s financial position. The NPV model will be presented along-side Monte-Carlo simulations to reveal the distribution of probable free cash flows and the likelihood of future earnings. In addition to these quantitative factors, we also examine the compensation plans of GALT’s executives to assess alignment with shareholders. At the conclusion of this analysis, it is our intention for readers to understand GALT’s business plan and the company’s financial standing to arrive at a sound investment decision.